VAIA
TPTX

Virtus Alternative Investment Advisers’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Virtus Alternative Investment Advisers’s Portfolio TPTX Stock Details TPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-66
Closed -$8K – 260
2020
Q4 		$8K Sell
66
-64
-49% -$7.01K 0.12% 96
2020
Q3 		$11K Sell
130
-131
-50% -$9.13K 0.2% 243
2020
Q2 		$17K Sell
261
-244
-48% -$14.1K 0.27% 98
2020
Q1 		$23K Buy
+505
New +$26.8K 0.32% 84

Other funds holding TPTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Virtus Alternative Investment Advisers's TPTX Position: Q1 2021 in Review

Virtus Alternative Investment Advisers sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q1 2021, closing a stake of 66 shares — an estimated $8K sold.

Virtus Alternative Investment Advisers first reported a position in TPTX in Q1 2020 and held it in 4 quarters. The position peaked at $23K in Q1 2020. 202 funds tracked by Wall St. Rank hold TPTX as of Q1 2021.

  • Virtus Alternative Investment Advisers reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Virtus Alternative Investment Advisers sold 66 Turning Point Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $8K.
  • Virtus Alternative Investment Advisers first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q1 2020 and held it in 4 quarters.
  • Virtus Alternative Investment Advisers's Turning Point Therapeutics, Inc. Common Stock position peaked at $23K in Q1 2020.
  • 202 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q1 2021.

Based on Virtus Alternative Investment Advisers's 13F filing for Q1 2021.